Polymorphic nanobody crystals as long‐acting intravitreal therapy for wet age‐related macular degeneration

MLA

Shuqian Zhu, et al. “Polymorphic Nanobody Crystals as Long‐acting Intravitreal Therapy for Wet Age‐related Macular Degeneration.” Bioengineering & Translational Medicine, vol. 8, no. 6, Nov. 2023. EBSCOhost, https://doi.org/10.1002/btm2.10523.

APA

Shuqian Zhu, Shilong Fan, Tianxin Tang, Jinliang Huang, Heng Zhou, Chengnan Huang, Youxin Chen, & Feng Qian. (2023). Polymorphic nanobody crystals as long‐acting intravitreal therapy for wet age‐related macular degeneration. Bioengineering & Translational Medicine, 8(6). https://doi.org/10.1002/btm2.10523

Chicago

Shuqian Zhu, Shilong Fan, Tianxin Tang, Jinliang Huang, Heng Zhou, Chengnan Huang, Youxin Chen, and Feng Qian. 2023. “Polymorphic Nanobody Crystals as Long‐acting Intravitreal Therapy for Wet Age‐related Macular Degeneration.” Bioengineering & Translational Medicine 8 (6). doi:10.1002/btm2.10523.